Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-18

FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approved a supplemental application for PEPCID AC MAXIMUM STRENGTH (famotidine) from Kenvue Brands LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PEPCID AC MAXIMUM STRENGTH (FAMOTIDINE)

Snippet

SUPPL AP for PEPCID AC MAXIMUM STRENGTH (FAMOTIDINE)